DRUG NEWS: New use for an anticonvulsant

June 2004 
Volume 34  Number 6
Pages 30 - 30
  PDF Version Available!


  • Source

    The anticonvulsant drug topiramate (Topamax) can significantly reduce the frequency of a person's migraines, according to a new study. Plus, the drug's benefits begin the first month of treatment.

    In the study, 483 patients who typically experienced 3 to 12 migraines per month were randomly selected to receive either topiramate or a placebo for 26 weeks. Patients in the topiramate group were assigned to take one of three dosages: 50 mg/day, 100 mg/day, or 200 mg/day.

    Patients who took 100 mg/day or 200 mg/day of the drug had about two fewer migraines per month than before starting treatment and used less rescue medication. At these dosages, topiramate effectively reduced migraine frequency within the first month of treatment and the benefit continued for the duration of the study. Those taking the 50 mg/day dose of topiramate and those taking the placebo reported no significant reductions in migraine frequency.

    Regardless ...

Purchase Now !

To purchase this item, follow the instructions below. If you’re not already logged in, be sure to enter your login information below to ensure that your item is saved to your File Drawer after you purchase it.

Not a member? Join now for Free!

1) If you're not already logged in, enter your information below to save this item in your File Drawer for future viewing.

User name:


Forgot your user name or password?
2)  If you have a coupon or promotional code, enter it
here.(If not, just click Continue.

Digital Coupon: (optional)

3)  Click Continue to go to the next screen, where
you'll enter your payment details.

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles Recommended Nursing Articles Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events